Market Tracker

09/30 6:05pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.13
Data as of Sep 30
 +0.57 / +7.54%
Today’s Change
6.12
Today|||52-Week Range
31.73
-47.31%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.56
Today’s open7.61
Day’s range7.52 - 8.30
Volume43,499
Average volume (3 months)60,173
Market cap$75.3M
Dividend yield--
Data as of 3:57pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...-0.10-1.44%
ASMBAssembly Biosciences...-0.05-0.61%
IPCIIntelliPharmaCeutics...-0.07-2.27%
MNOVMediciNova Inc+0.04+1.36%
Data as of 3:59pm ET, 09/30/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts